Delisting risk
Palatin Technologies (PTN)
Develops melanocortin agonists for rare obesity disorders through a partner-led pipeline.
$13.08
At close+1.57 (+13.64%)
Something off on this page? Send us feedback.
Next report
Nov 16, 2026
in 74 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Nov '26
Reported−$19.50−$0.12−$9.00−$4.14$4.26−$2.86−$0.37Pending
Estimate−$0.51−$0.42−$0.17−$9.50—−$2.35−$1.24—
Surprise−3,723.5%+71.4%−5,194.1%+56.4%—−21.5%+70.2%—
RevenueReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Nov '26
Reported————$8.8M$116.0K$3.9MPending
Estimate$314.0K—$7.9M——$25.0K$1.3M—
Surprise—————+364.1%+205.5%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Sep 2026 | −$1.20 | — | — |
| May 2026 | −$1.24 | −$0.37 | +70.2% |
| Feb 2026 | −$2.35 | −$2.86 | −21.5% |
| Nov 2025 | — | $4.26 | — |
| Sep 2025 | −$9.50 | −$4.14 | +56.4% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | — | — | — | — | — | — | — |
| Sep 2, 2026 | −$1.20 | — | — | $1.5M | — | — | — |
| May 13, 2026 | −$1.24 | −$0.37 | +70.2% | $1.3M | $3.9M | +205.5% | −9.8% |
| Feb 17, 2026 | −$2.35 | −$2.86 | −21.5% | $25.0K | $116.0K | +364.1% | +10.0% |
| Nov 14, 2025 | — | $4.26 | — | — | $8.8M | — | +17.9% |
| Sep 23, 2025 | −$9.50 | −$4.14 | +56.4% | — | — | — | +2.9% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||||||
| May 14, 2025 | |||||||
| Feb 13, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Sep 30, 2024 | |||||||
| May 15, 2024 | |||||||
| Feb 14, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Sep 28, 2023 | |||||||
| May 16, 2023 | |||||||
| Feb 14, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Sep 22, 2022 | |||||||
| May 17, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Sep 29, 2021 | |||||||
| May 17, 2021 | |||||||
| Feb 17, 2021 | |||||||
| Nov 17, 2020 | |||||||
| Sep 28, 2020 | |||||||
| May 12, 2020 | |||||||
| Feb 11, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Sep 12, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 12, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Sep 13, 2018 | |||||||
| May 15, 2018 | |||||||
| Feb 12, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Sep 25, 2017 | |||||||
| May 16, 2017 | |||||||
| Feb 9, 2017 | |||||||
| Nov 15, 2016 | |||||||
| Sep 20, 2016 | |||||||
| May 17, 2016 | |||||||
| Feb 12, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Sep 21, 2015 | |||||||